Actinogen Medical Ltd

Research Actinogen Medical Ltd (ACW) on Bullrun: market cap AUD 113.40M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerACW
• ExchangeAU
• CountryAustralia
• SectorHealthcare
• IndustryBiotechnology
• CurrencyAUD
• Market capAUD 113.40M
• Financial periodFY2025
• Net income-AUD 14.73M
• Free cash flow-AUD 7.59M

Valuation Snapshot

latest market cap is AUD 113.40M.

About Actinogen Medical Ltd

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme that achieves target engagement in the brain for the treatment of Alzheimer's disease, major depressive disorder, fragile x syndrome, and other neurological diseases.

Frequently asked questions

What is Actinogen Medical Ltd's market cap?

Actinogen Medical Ltd's market capitalization is AUD 113.40M.

What does Actinogen Medical Ltd do?

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia.